Showing results (901-910 of 927) with videos related to

Sort By:
Pageof 93
Nature Communications|February 6, 2021
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activationChuan Hong, Noel J Byrne, Beata Zamlynny, et al.
Nature|April 6, 2017
Structural basis for selectivity and diversity in angiotensin II receptorsHaitao Zhang, Gye Won Han, Alexander Batyuk, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2005
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinaseJohn T Sisko, Thomas J Tucker, Mark T Bilodeau, et al.
Journal of Medical Genetics|May 22, 2016
New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) studyInga Plaskocinska, Hannah Shipman, James Drummond, et al.
The Journal of Infectious Diseases|December 8, 2017
A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous InoculationSean C Murphy, Elizabeth R Duke, Kelly J Shipman, et al.
The Journal of Investigative Dermatology|November 12, 2021
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with PsoriasisKonstantinos Douroudis, Ravi Ramessur, Ines A Barbosa, et al.
Nature Communications|August 14, 2025
A systemic risk assessment methodological framework for the global polycrisisAjay Gambhir, Michael J Albert, Sylvanus S P Doe, et al.
Developmental Cell|December 15, 2012
The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood compositionRadu V Stan, Dan Tse, Sophie J Deharvengt, et al.
Elife|June 11, 2024
The interferon-rich skin environment regulates Langerhans cell ADAM17 to promote photosensitivity in lupusThomas Morgan Li, Victoria Zyulina, Ethan S Seltzer, et al.
JCI Insight|February 22, 2023
Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding grooveTeresa Tsakok, Jake Saklatvala, Theo Rispens, et al.
Pageof 93